Lin Xichen (CIK 1962926) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-02). Recent activity: Buy GPCR (17,817 shares), Sell GPCR (17,817 shares), Buy GPCR (11,817 shares), Sell GPCR (11,817 shares), Buy GPCR (11,817 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | Structure Therapeutics Inc. (GPCR) | CHIEF SCIENTIFIC OFFICER | Buy | 17,817 | $6,058 |
| 2026-09-02 | Structure Therapeutics Inc. (GPCR) | CHIEF SCIENTIFIC OFFICER | Sell | 17,817 | $0 |
| 2026-08-19 | Structure Therapeutics Inc. (GPCR) | CHIEF SCIENTIFIC OFFICER | Buy | 11,817 | $4,018 |
| 2026-08-19 | Structure Therapeutics Inc. (GPCR) | CHIEF SCIENTIFIC OFFICER | Sell | 11,817 | $0 |
| 2026-08-05 | Structure Therapeutics Inc. (GPCR) | CHIEF SCIENTIFIC OFFICER | Buy | 11,817 | $4,018 |
| 2026-08-05 | Structure Therapeutics Inc. (GPCR) | CHIEF SCIENTIFIC OFFICER | Sell | 11,817 | $0 |
| 2026-07-15 | Structure Therapeutics Inc. (GPCR) | CHIEF SCIENTIFIC OFFICER | Buy | 23,634 | $8,036 |
| 2026-07-15 | Structure Therapeutics Inc. (GPCR) | CHIEF SCIENTIFIC OFFICER | Sell | 23,634 | $0 |
| 2026-06-29 | Structure Therapeutics Inc. (GPCR) | CHIEF SCIENTIFIC OFFICER | Buy | 23,634 | $8,036 |
| 2026-06-29 | Structure Therapeutics Inc. (GPCR) | CHIEF SCIENTIFIC OFFICER | Sell | 23,634 | $0 |
| 2026-03-23 | Structure Therapeutics Inc. (GPCR) | CHIEF SCIENTIFIC OFFICER | Buy | 43,368 | $0 |
| 2026-03-05 | Structure Therapeutics Inc. (GPCR) | CHIEF SCIENTIFIC OFFICER | Sell | 18,735 | $393,248 |
| 2025-08-20 | Structure Therapeutics Inc. (GPCR) | CHIEF SCIENTIFIC OFFICER | Sell | 12,846 | $87,867 |
| 2025-07-03 | Structure Therapeutics Inc. (GPCR) | CHIEF SCIENTIFIC OFFICER | Sell | 6,441 | $51,013 |
| 2025-07-03 | Structure Therapeutics Inc. (GPCR) | CHIEF SCIENTIFIC OFFICER | Buy | 57,078 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-02